2.) What do you mean "corner the market" .... the only thing keeping COV-Surgical afloat in Stapling is the Endo GIA.. otherwise their tackers, linear stapler, open tools, trocars, suture, soft tissue repair etc. are all trounced by Ethicon and beaten to a pulp.... so I am not sure which market they are "cornering" unless if by corner you mean "add to their marginal sales figures"
3.) Why would they buy an upstart stapling company on the rise at a premium when they have already been developing their own 5mm stapler for years? This is an upstart 5mm stapling company that is microscopic in the grand scheme of the market, so they will NEVER be able to compete with Surgical or Ethicon... although they will try, much like Powered Medical did when they tried to revolutionize the market... but the same thing will happen to them that happened to Powered. They will go bankrupt and COV or Ethicon can buy them for pennies ont he dollar for the IP alone and then discontinue their product line and incorporate it into their own.
Your response was very much appreciated. I see less Ethicon used compared to Covidien but then again I just see the orders. Cardica device is being submitted for 510 approval process and is being used in Europe from what I've heard. Recently, Applied Medical bought some 10 % of the company CRDC stock with JNJ rumored to be looking at CRDC as well. Maybe COV should take a pass and continue working on their 5mm stapler. I'd hate to see COV waste money or lose out.